{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:30:59Z","timestamp":1772807459414,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Taiwan Ministry of Science and Technology","doi-asserted-by":"crossref","award":["109-2314-B-002-185-MY3"],"award-info":[{"award-number":["109-2314-B-002-185-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pneumonia"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This study aimed to assess the diagnostic and prognostic value of <jats:italic>Aspergillus<\/jats:italic>-specific IgG (<jats:italic>Asp<\/jats:italic>-IgG) for invasive pulmonary aspergillosis (IPA) in non-neutropenic non-hematologic patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Between November 2019 and February 2022, we recruited 40 non-neutropenic, non-hematologic IPA patients from Taiwan and measured serum <jats:italic>Asp<\/jats:italic>-IgG levels using Phadia, Thermofisher. A positive <jats:italic>Asp<\/jats:italic>-IgG test was defined as a level\u2009&gt;\u200940 mgA\/L. We evaluated the association between <jats:italic>Asp<\/jats:italic>-IgG levels and overall survival, as well 90-day mortality rate of IPA patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of the 40 participants, 11 (27.5%) tested positive for <jats:italic>Asp<\/jats:italic>-IgG, while 16 (40%) had positive galactomannan antigen (optical density\u2009&gt;\u20091). Higher <jats:italic>Asp<\/jats:italic>-IgG levels were associated with improved overall survival (HR: 0.22, 95% CI: 0.05\u20130.99, <jats:italic>p<\/jats:italic>\u2009=\u20090.035) in multivariable Cox regression. The overall 90-day mortality rate was 65% (26\/40). We found that patients with low <jats:italic>Asp<\/jats:italic>-IgG levels (\u2264\u200940 mgA\/L) had a borderline higher 90-day mortality rate compared to patients with high <jats:italic>Asp<\/jats:italic>-IgG levels (OR: 3.15, 95% CI: 0.75\u201313.28, <jats:italic>p<\/jats:italic>\u2009=\u20090.118). Stratifying by serum galactomannan and <jats:italic>Aspergillus<\/jats:italic> IgG levels, patients with elevated serum GM and low <jats:italic>Asp<\/jats:italic>-IgG had the highest 90-day mortality (80%, 8\/10), followed by patients with low serum GM and low <jats:italic>Asp<\/jats:italic>-IgG (68.4%, 13\/19).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p><jats:italic>Asp<\/jats:italic>-IgG was positive in approximately one-fourth of non-neutropenic IPA patients. <jats:italic>Asp<\/jats:italic>-IgG may hold potential as a clinical prognostic factor for IPA. Further studies are required to validate this finding.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41479-024-00154-8","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T01:02:19Z","timestamp":1730768539000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Seroprevalence and prognostic value of Aspergillus-specific IgG among non-neutropenic invasive pulmonary aspergillosis patients: a prospective multicenter study"],"prefix":"10.1186","volume":"16","author":[{"given":"Meng-Rui","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsu-Liang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung-Hsuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Jung","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Ta","family":"Keng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Ling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jann-Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chau-Chyun","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inn-Wen","family":"Chong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"issue":"3","key":"154_CR1","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1086\/318483","volume":"32","author":"SJ Lin","year":"2001","unstructured":"Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis. 2001;32(3):358\u201366.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"154_CR2","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1093\/jac\/dkw111","volume":"71","author":"F Barchiesi","year":"2016","unstructured":"Barchiesi F, Santinelli A, Biscotti T, Greganti G, Giannini D, Manso E. Delay of antifungal therapy influences the outcome of invasive aspergillosis in experimental models of infection. J Antimicrob Chemother. 2016;71(8):2230\u20133.","journal-title":"J Antimicrob Chemother"},{"key":"154_CR3","doi-asserted-by":"crossref","unstructured":"Lackner N, Thome C, Ofner D, Joannidis M, Mayerhofer T, Arora R, Samardzic E, Posch W, Breitkopf R, Lass-Florl C: COVID-19 Associated Pulmonary Aspergillosis: Diagnostic Performance, Fungal Epidemiology and Antifungal Susceptibility. J Fungi (Basel) 2022;8(2):93.","DOI":"10.3390\/jof8020093"},{"issue":"8","key":"154_CR4","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1007\/s00134-020-06091-6","volume":"46","author":"PE Verweij","year":"2020","unstructured":"Verweij PE, Rijnders BJA, Bruggemann RJM, Azoulay E, Bassetti M, Blot S, Calandra T, Clancy CJ, Cornely OA, Chiller T, et al. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive Care Med. 2020;46(8):1524\u201335.","journal-title":"Intensive Care Med"},{"issue":"9","key":"154_CR5","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.cmi.2021.02.005","volume":"27","author":"C Lass-Florl","year":"2021","unstructured":"Lass-Florl C, Samardzic E, Knoll M. Serology anno 2021-fungal infections: from invasive to chronic. Clin Microbiol Infect. 2021;27(9):1230\u201341.","journal-title":"Clin Microbiol Infect"},{"key":"154_CR6","doi-asserted-by":"crossref","unstructured":"Yusuf E, Vonk A, van den Akker JPC, Bode L, Sips GJ, Rijnders BJA, de Steenwinkel J, Verkaik NJ, Vogel M, van der Eerden M et al: Frequency of Positive Aspergillus Tests in COVID-19 Patients in Comparison to Other Patients with Pulmonary Infections Admitted to the Intensive Care Unit. J Clin Microbiol 2021;59(3):e02278\u201320.","DOI":"10.1128\/JCM.02278-20"},{"key":"154_CR7","first-page":"174","volume":"122","author":"TF Patterson","year":"2011","unstructured":"Patterson TF. Clinical utility and development of biomarkers in invasive aspergillosis. Trans Am Clin Climatol Assoc. 2011;122:174\u201383.","journal-title":"Trans Am Clin Climatol Assoc"},{"issue":"10","key":"154_CR8","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1086\/503427","volume":"42","author":"CD Pfeiffer","year":"2006","unstructured":"Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis. 2006;42(10):1417\u201327.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"154_CR9","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","volume":"24","author":"AJ Ullmann","year":"2018","unstructured":"Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Florl C, Lewis RE, Munoz P, Verweij PE, et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect. 2018;24(Suppl 1):e1\u201338.","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"154_CR10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/mmy\/myv020","volume":"53","author":"ID Page","year":"2015","unstructured":"Page ID, Richardson M, Denning DW. Antibody testing in aspergillosis\u2013quo vadis? Med Mycol. 2015;53(5):417\u201339.","journal-title":"Med Mycol"},{"issue":"1","key":"154_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12890-020-1125-y","volume":"20","author":"Q Yu","year":"2020","unstructured":"Yu Q, He J, Xing B, Li X, Qian H, Zhang H, Xu M, Peng H. Potential value of serum Aspergillus IgG antibody detection in the diagnosis of invasive and chronic pulmonary aspergillosis in non-agranulocytic patients. BMC Pulm Med. 2020;20(1):89.","journal-title":"BMC Pulm Med"},{"issue":"8","key":"154_CR12","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/myc.12765","volume":"61","author":"R Dobias","year":"2018","unstructured":"Dobias R, Jaworska P, Tomaskova H, Kanova M, Lyskova P, Vrba Z, Holub C, Svobodova L, Hamal P, Raska M. Diagnostic value of serum galactomannan, (1,3)-beta-d-glucan, and Aspergillus fumigatus-specific IgA and IgG assays for invasive pulmonary aspergillosis in non-neutropenic patients. Mycoses. 2018;61(8):576\u201386.","journal-title":"Mycoses"},{"issue":"2 Suppl 2","key":"154_CR13","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.jaci.2009.09.046","volume":"125","author":"HW Schroeder Jr","year":"2010","unstructured":"Schroeder HW Jr, Cavacini L. Structure and function of immunoglobulins. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S41-52.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"154_CR14","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jinf.2015.11.003","volume":"72","author":"ID Page","year":"2016","unstructured":"Page ID, Richardson MD, Denning DW. Comparison of six Aspergillus-specific IgG assays for the diagnosis of chronic pulmonary aspergillosis (CPA). J Infect. 2016;72(2):240\u20139.","journal-title":"J Infect"},{"issue":"6","key":"154_CR15","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","volume":"71","author":"JP Donnelly","year":"2020","unstructured":"Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, Clancy CJ, Wingard JR, Lockhart SR, Groll AH, et al. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020;71(6):1367\u201376.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"154_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","volume":"186","author":"SI Blot","year":"2012","unstructured":"Blot SI, Taccone FS, Van den Abeele AM, Bulpa P, Meersseman W, Brusselaers N, Dimopoulos G, Paiva JA, Misset B, Rello J, et al. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am J Respir Crit Care Med. 2012;186(1):56\u201364.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"154_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13613-021-00827-3","volume":"11","author":"J Hamam","year":"2021","unstructured":"Hamam J, Navellou JC, Bellanger AP, Bretagne S, Winiszewski H, Scherer E, Piton G, Millon L. Collaborative Rg: New clinical algorithm including fungal biomarkers to better diagnose probable invasive pulmonary aspergillosis in ICU. Ann Intensive Care. 2021;11(1):41.","journal-title":"Ann Intensive Care"},{"key":"154_CR18","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.3389\/fmicb.2019.01438","volume":"10","author":"H Li","year":"2019","unstructured":"Li H, Rui Y, Zhou W, Liu L, He B, Shi Y, Su X. Role of the Aspergillus-Specific IgG and IgM Test in the Diagnosis and Follow-Up of Chronic Pulmonary Aspergillosis. Front Microbiol. 2019;10:1438.","journal-title":"Front Microbiol"},{"issue":"5","key":"154_CR19","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.chom.2012.04.004","volume":"11","author":"A Casadevall","year":"2012","unstructured":"Casadevall A, Pirofski LA. Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases. Cell Host Microbe. 2012;11(5):447\u201356.","journal-title":"Cell Host Microbe"},{"issue":"1","key":"154_CR20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4489\/MYCO.2011.39.1.040","volume":"39","author":"YA Mahmoud","year":"2011","unstructured":"Mahmoud YA, Al-Ghamdi AY, Abd El-Zaher EH. A Protective Mechanism in Lungs of Rats Experimentally Infected with Aspergillus fumigatus. Mycobiology. 2011;39(1):40\u20134.","journal-title":"Mycobiology"},{"key":"154_CR21","doi-asserted-by":"crossref","unstructured":"Collier DA, Ferreira I, Kotagiri P, Datir RP, Lim EY, Touizer E, Meng B, Abdullahi A, Collaboration C-NBC-, Elmer A et al: Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2. Nature 2021, 596(7872):417\u2013422.","DOI":"10.1101\/2021.02.03.21251054"},{"key":"154_CR22","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1471-2431-10-48","volume":"10","author":"YS Youn","year":"2010","unstructured":"Youn YS, Lee KY, Hwang JY, Rhim JW, Kang JH, Lee JS, Kim JC. Difference of clinical features in childhood Mycoplasma pneumoniae pneumonia. BMC Pediatr. 2010;10:48.","journal-title":"BMC Pediatr"},{"issue":"3","key":"154_CR23","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1128\/IAI.01091-09","volume":"78","author":"EK Rodland","year":"2010","unstructured":"Rodland EK, Ueland T, Pedersen TM, Halvorsen B, Muller F, Aukrust P, Froland SS. Activation of platelets by Aspergillus fumigatus and potential role of platelets in the immunopathogenesis of Aspergillosis. Infect Immun. 2010;78(3):1269\u201375.","journal-title":"Infect Immun"},{"key":"154_CR24","doi-asserted-by":"crossref","unstructured":"Chebbo M, Duez C, Alessi MC, Chanez P, Gras D: Platelets: a potential role in chronic respiratory diseases? Eur Respir Rev 2021;30(161):210062.","DOI":"10.1183\/16000617.0062-2021"},{"key":"154_CR25","doi-asserted-by":"crossref","unstructured":"Gago S, Denning DW, Bowyer P: Pathophysiological aspects of Aspergillus colonization in disease. Medical mycology 2019, 57(Supplement_2):S219-S227.","DOI":"10.1093\/mmy\/myy076"},{"issue":"4","key":"154_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2020.115274","volume":"99","author":"Z Wu","year":"2021","unstructured":"Wu Z, Wang L, Tan L, Wu J, Chen Z, Hu M. Diagnostic value of galactomannan in serum and bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in non-neutropenic patients. Diagn Microbiol Infect Dis. 2021;99(4): 115274.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"7","key":"154_CR27","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1128\/JCM.00345-17","volume":"55","author":"W Zhou","year":"2017","unstructured":"Zhou W, Li H, Zhang Y, Huang M, He Q, Li P, Zhang F, Shi Y, Su X. Diagnostic Value of Galactomannan Antigen Test in Serum and Bronchoalveolar Lavage Fluid Samples from Patients with Nonneutropenic Invasive Pulmonary Aspergillosis. J Clin Microbiol. 2017;55(7):2153\u201361.","journal-title":"J Clin Microbiol"},{"key":"154_CR28","doi-asserted-by":"crossref","unstructured":"Kluge S, Strauss R, Kochanek M, Weigand MA, Rohde H, Lahmer T: Aspergillosis: Emerging risk groups in critically ill patients. Med Mycol 2021;60(1):myab064.","DOI":"10.1093\/mmy\/myab064"},{"issue":"4","key":"154_CR29","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41590-021-00908-2","volume":"22","author":"SC Chen","year":"2021","unstructured":"Chen SC. Taiwan\u2019s experience in fighting COVID-19. Nat Immunol. 2021;22(4):393\u20134.","journal-title":"Nat Immunol"},{"issue":"2","key":"154_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jointm.2021.07.001","volume":"1","author":"G Dimopoulos","year":"2021","unstructured":"Dimopoulos G, Almyroudi MP, Myrianthefs P, Rello J. COVID-19-Associated Pulmonary Aspergillosis (CAPA). J Intensive Med. 2021;1(2):71\u201380.","journal-title":"J Intensive Med"},{"issue":"1","key":"154_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.diagmicrobio.2018.01.001","volume":"91","author":"ID Page","year":"2018","unstructured":"Page ID, Baxter C, Hennequin C, Richardson MD, van Hoeyveld E, van Toorenenbergen AW, Denning DW. Receiver operating characteristic curve analysis of four Aspergillus-specific IgG assays for the diagnosis of chronic pulmonary aspergillosis. Diagn Microbiol Infect Dis. 2018;91(1):47\u201351.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"154_CR32","doi-asserted-by":"crossref","unstructured":"Tirelli C, M DEA, Piloni D, Sacchi L, Mariani F, Testa G, Torre C, Ciprandi G, Centanni S, Marseglia G et al: Serum Aspergillus-specific IgE, IgG and IgG4 immunoglobulins assessment in the work-up of Invasive Pulmonary Aspergillosis: a prospective cohort study. Minerva Med 2022.","DOI":"10.23736\/S0026-4806.22.08245-3"},{"key":"154_CR33","doi-asserted-by":"crossref","unstructured":"Lu Y, Liu L, Li H, Chen B, Gu Y, Wang L, Feng C, Chen C, Chen Y, Sun W et al: The clinical value of Aspergillus-specific IgG antibody test in the diagnosis of nonneutropenic invasive pulmonary aspergillosis. Clin Microbiol Infect 2023.","DOI":"10.2139\/ssrn.4231232"},{"key":"154_CR34","doi-asserted-by":"publisher","first-page":"1060727","DOI":"10.3389\/fmicb.2022.1060727","volume":"13","author":"CW Hsiao","year":"2022","unstructured":"Hsiao CW, Yen TH, Wu YC, Chen JP, Chen YY, Huang WN, Chen YH, Chen YM. Comparison of Aspergillus-specific antibody cut-offs for the diagnosis of aspergillosis. Front Microbiol. 2022;13:1060727.","journal-title":"Front Microbiol"},{"issue":"2","key":"154_CR35","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jiph.2021.12.015","volume":"15","author":"Z Jiang","year":"2022","unstructured":"Jiang Z, Chen S, Zhu Q, Xiao Y, Qu J. COVID-19-associated pulmonary aspergillosis in a tertiary care center in Shenzhen City. J Infect Public Health. 2022;15(2):222\u20137.","journal-title":"J Infect Public Health"}],"container-title":["Pneumonia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41479-024-00154-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41479-024-00154-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41479-024-00154-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T01:03:06Z","timestamp":1730768586000},"score":1,"resource":{"primary":{"URL":"https:\/\/pneumonia.biomedcentral.com\/articles\/10.1186\/s41479-024-00154-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["154"],"URL":"https:\/\/doi.org\/10.1186\/s41479-024-00154-8","relation":{},"ISSN":["2200-6133"],"issn-type":[{"value":"2200-6133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,5]]},"assertion":[{"value":"25 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was prospectively conducted in accordance with ethical principles and standards. The Institutional Review Boards of all participating hospitals granted approval for the study (Approval numbers: 108\u2013079-E and KMUHIRB-E(I)-202001118). Informed consent was obtained from all study participants prior to their inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable since the manuscript does not contain data from any individual.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}